EPHB4 and neoplasm: Our findings reveal that EphB4 knockdown in cancer cells leads to an increase in the development of distant metastases, characterized by a pro-metastatic cancer cell phenotype, systemic immunosuppression, and enhanced infiltration of CD4+ T cells and Tregs into the tumor.